In the setting of innate activation, BRD4’s association with sequence specific transcription factors, such as RELA/NFκB (78) and AP1 (64) may provide independent mechanisms for targeting the BRD4 CRC to inducible ISGs. This evidence concerns the gene NFKB1 and colorectal carcinoma.